Salivary Circular RNAs Hsa-Circ-0001874 and Hsa-Circ-0001971 as novel biomarkers for the diagnosis of oral squamous cell carcinoma

Abstract

Background/Aims: Recent studies have demonstrated that circular RNAs (circRNAs) can serve as potential molecular markers for disease diagnosis. However, little is known about their diagnostic potential for oral squamous cell carcinoma (OSCC). This study aimed to determine the expression of circRNAs in the saliva of OSCC patients to identify novel biomarkers for OSCC screening. Methods: Microarray screening of circRNA was performed to identify differentially expressed circRNAs in saliva from 3 OSCC patients compared with 3 healthy controls. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to validate the results, and the association between these confirmed salivary circRNAs and clinicopathological features was analyzed using the chi-squared test. A receiver operating characteristic (ROC) curve was constructed to evaluate the diagnostic value of the circRNAs identified. Preoperative expression and postoperative expression (1 month after the surgery) of hsa-circ-0001874 and hsa-circ-0001971 was also determined. Results: Our results indicated 12 upregulated and 20 downregulated circRNAs in the saliva from the OSCC patients compared with that from the healthy controls. Among the differentially expressed circRNAs, hsa-circ-0001874, hsa-circ-0001971, and hsa-circ-0008068 were upregulated and hsa-circ-0000140, hsa-circ-0002632, and hsa-circ-0008792 were downregulated in the OSCC group versus the healthy group. Clinical data indicated that salivary hsa-circ-0001874 was correlated with TNM stage (P=0.006) and tumor grade (P=0.023) and that hsa-circ-0001971 was correlated with TNM stage (P=0.019). The combination of hsa-circ-0001874 and hsa-circ-0001971 showed an area under the ROC curve of 0.922 (95% confidence interval, 0.883-0.961; P< 0.001). The risk score based on the combination of hsa-circ-0001874 and hsa-circ-0001971 also discriminated patients with OSCC from patients with oral leukoplakia (P< 0.001). Moreover, the expression levels of salivary hsa-circ-0001874 and hsa-circ-0001971 were clearly decreased in the postoperative samples compared with preoperative samples (P< 0.001). Conclusions: This is the first study to demonstrate the potential of salivary hsa-circ-0001874 and hsa-circ-0001971 as biomarkers for the diagnosis of OSCC.